Kauppalehti1h
ThreatLocker® launches new solutions, further advances Zero Trust security resilience and adoption
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- ThreatLocker®, a global leader in Zero Trust cybersecurity, has unveiled new solutions that further advance its platform’s security and efficiency. The ...
Kauppalehti5h
Philips publishes its Annual Report 2024
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2024. Philips’ Annual Report 2024 will be on the agenda of the Annual General Meeting of ...
Kauppalehti9h
Pacific Green Signs Agreement to Sell Its 250MW / 500MWh Limestone Coast North Battery Energy Park Development
The Limestone Coast North Energy Park is Pacific Green’s 250MW / 500MWh battery energy storage development in the Limestone Coast region of South Australia (“Limestone Coast North”) which will begin ...
Kauppalehti18h
Mandalay Resources Announces Record Financial Performance in 2024, Generating $69 Million in Free Cash Flow
Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) announced its financial results for the fourth quarter and year ended December 31, 2024. The Company delivered ...
Kauppalehti11h
DNA to completely withdraw from X
By the end of February 2025, DNA will completely withdraw from the social media platform X, and will no longer provide content, communication or customer service on the channel. At the same time, DNA ...
Kauppalehti13h
SIKA WITH RECORD RESULTS – JUMP IN NET PROFIT OF 17.4%
SIKA WITH RECORD RESULTS – JUMP IN NET PROFIT OF 17.4% Proposed dividend per share of CHF 3.60 (previous year: CHF 3.30) ...
Kauppalehti22h
Islamic Islamic Dialogue in Bahrain Affirms: " What is Needed is a Constructive Dialogue of Understanding that Embraces the Many Elements of Unity"
Participants in the Islamic Islamic Dialogue Conference, titled: “One Nation.. A Shared Destiny” expressed their deepest gratitude and appreciation in their final statement to His Majesty King Hamad ...
Kauppalehti6h
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) today announced the availability of SELARSDI™ (ustekinumab-aekn) ...
Kauppalehti23h
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Kauppalehti1d
NevGold Discovers Samples With Up to 10% Antimony at the Limousine Butte Gold-Antimony Project in Nevada
NevGold is an exploration and development company targeting large-scale mineral systems in the proven districts of Nevada and Idaho. NevGold owns a 100% interest in the Limousine Butte and Cedar Wash ...
Kauppalehti1d
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Dr. Frank Mathias, Chief Executive Officer of OXB, said, “We are delighted that Boehringer Ingelheim is using OXB’s proprietary lentiviral vector manufacturing technology, to produce lentiviral vector ...
Kauppalehti1d
T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors
SAN FRANCISCO and BERLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer ...